OPNT
$27.07
Opiant Pharmaceuticals
($2.12)
(7.26%)
OPNT
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  $0.10
Revenue:  $14.38 Mil
Thursday
Feb 10
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OPNT reports earnings?
Beat
Meet
Miss

Where is OPNT's stock price going from here?
Up
Flat
Down
Stock chart of OPNT
Analysts
Summary of analysts' recommendations for OPNT
Score
Grade
Pivots
Resistance
$32.74
$30.94
$29.01

$27.20

Support
$25.27
$23.46
$21.53
Tweet
Growth
Description
Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company. It is engaged in developing opioid antagonist treatments for substance use, addictive and eating disorders. Opiant Pharmaceuticals Inc., formerly known as Lightlake Therapeutics, Inc., is based in New York.